GLI3 and Alzheimer disease: As Shh treatment increased human Treg differentiation in vitro, and in mice, decreasing Hh levels in Shh+/– skin increased AD severity, but increasing Shh expression in Gli3+/– skin decreased AD severity, we hypothesized that individuals who suffer from AD might have lower baseline levels of expression of Hh pathway components in skin than healthy individuals.